Background. Arrhythmias are common in patients who have developed ventricular enlargement after myocardial infarction.
Methods and Results. A prospective study was undertaken to assess the relation between ventricular dilatation and the development of late potentials after myocardial infarction. Echocardiograms and signal-averaged ECGs were recorded on days 1, 3, 7, and 42 in 52 patients with a first anterior myocardial infarction. Twenty-nine percent of patients were late potential-positive on their initial signal-averaged ECG recorded on the day of admission. The incidence of late potentials rose during the next week to a peak of 42% at day 7, declining to 13% by day 42. The presence of late potentials on the day of admission was associated with an increase in end-diastolic volume index of 16.1±6.0 m1m2 (mean±SEM), compared with a decrease of 4.7±2.7 mL/m2 among late potential-negative patients (P<.006). Qualitatively similar results were evident for late potentials on day 3 and day 7. By contrast, there was no association between late potentials on day 42 and ventricular dilatation. Marked dynamic changes in late potentials were evident during the first week. Patients with persistent late potentials (n=9) on all three recordings in the first week showed a marked increase in end-diastolic volume index of 213±8.1 mL/m2 (P<.005 in comparison with patients who were persistently negative [n=201). Patients demonstrating dynamic positivity (n= 15 ) not present on all three recordings in the first week showed no significant increase in end-diastolic volume index.
Conclusions. It is concluded that late potentials during the first week after infarction are associated with subsequent ventricular dilatation. These early-phase late potentials may be a manifestation of cell slippage. They arise before gross topographical enlargement and may serve as a predictor of ventricular dilatation. (Circulation. 1993:88:905-914.) KEY WORDS * infarcts * left ventricle Infarct expansion and ventricular remodeling are important determinants of ventricular function after myocardial infarction.' Ventricular function is in turn a major determinant of arrhythmogenesis and sudden death, yet little is known of the consequences of ventricular remodeling for arrhythmogenesis. That a relation may exist is evident in the well-known association between left ventricular aneurysm formation, an extreme form of infarct expansion, and susceptibility to arrhythmias.2 It is unclear, however, whether a similar association exists for lesser degrees of infarct expansion.
Indirect evidence supporting a relation between ventricular remodeling and arrhythmogenesis can be inferred from recent studies concerning the benefits of thrombolysis. Successful thrombolysis is known to prevent infarct expansion.3-5 Persistent occlusion of the infarct-related artery results in thinning and expansion of the infarct zone and an increase in ventricular dimensions. Several authors have shown that successful thrombolysis is also associated with a decreased inci-dence of late potential development.6-9 Furthermore, patients who have received thrombolytic therapy manifest a decreased susceptibility to sustained ventricular arrhythmias during programmed stimulation.10."1 However, the mechanism whereby reperfusion influences the arrhythmogenic substrate is unclear.
There are, moreover, similarities between the histological changes underlying infarct expansion and the pathophysiological processes underlying slow conduction and arrhythmogenesis. Infarct expansion initially involves myocyte stretch and slippage with loss of gap junctions in the peri-infarct zone.12 Subsequently, fibrosis develops between surviving myocytes.'3-'5 Either early slippage or late fibrosis or both might result in slow conduction and arrhythmogenesis.
The purpose of the present investigation was to assess the possible relation between ventricular remodeling and the development of an arrhythmogenic substrate after myocardial infarction. Patients with anterior myocardial infarction were studied because of their susceptibility to infarct expansion and the higher specificity of late potentials in this group. 16 Serial changes in ventricular volumes over the first 6 weeks after infarction were determined echocardiographically. These changes were correlated with the evolution of late potentials as an index of arrhythmia susceptibility.
Methods

Patients
Seventy-nine consecutive patients with a first acute anterior myocardial infarction were eligible for investigation. Myocardial infarction was diagnosed from the presence of two of three standard criteria: a history consistent with myocardial infarction, a creatine kinase rise greater than three times normal, and the development of new Q waves in the ECG. Patients were excluded if it was not possible to record a high-quality echocardiogram (19 patients). Other reasons for exclusion included the presence of bundle branch block or atrial fibrillation (2 patients) in the presenting ECG. Patients receiving treatment with steroids (1 patient) or nonsteroidal anti-inflammatory drugs (2 patients) were also excluded, since these agents may adversely influence ventricular remodeling.17'18 Three patients were unable or unwilling to give consent. Over a 10-month period, 52 patients entered the investigation.
The study was approved by the hospital's ethics committee.
Timing of Investigations
Initial echocardiograms were recorded within 12 hours and initial signal-averaged ECGs within 24 hours of admission to the coronary care unit (day 1). Echocardiograms and signal-averaged ECGs were repeated on day 3 after admission, on day 7 (before hospital discharge), and on day 42. With the exception of the initial echocardiogram, all echocardiograms and signal-averaged ECGs were recorded between 8 AM and 12 noon, at least 12 hours after the administration of any cardioactive drug. The echocardiographic and signal-averaging data sets were 95% and 96% complete, respectively. Creatine kinase was estimated daily for the first 3 days after admission.
Echocardiography
Two-dimensional echocardiographic images of the left ventricle were recorded on S-VHS tape with a Hewlett-Packard Sonos 500 machine. Standard apical four-chamber and apical two-chamber long-axis views were obtained on each visit, with the patient lying on his left side at an angle of 450, with breath held in end expiration. A simultaneous ECG tracing was recorded. Patients were entered into the study only if there was clear visualization of at least 90% of the endocardium in systole and diastole. The optimal transducer position was noted and marked with indelible ink for subsequent echocardiographic recordings.
Recordings were coded for subsequent analysis by a single operator blinded to the signal-averaging results. Videos were replayed through a computer-assisted video-overlay system. Signals from the computer, digitizer, and video were processed through a custom-built video mixer and displayed on a high-resolution monitor. Enddiastolic and end-systolic frames were selected, and the endocardial outline of each was traced with a digitizer pad and displayed on the monitor. The system differed from a frame-grabbing facility in that it allowed echocardiographic images to To avoid assumptions about the distribution of the data, nonparametric analyses were performed. The statistical significance of change in ventricular volumes 18 hours). One patient died of cardiogenic shock within 48 hours of admission. Five more patients died after hospital discharge during the 6-week follow-up period. All of these deaths were sudden. No patients received antiarrhythmic drugs during the study period. At hospital discharge, 48% of patients were on a ,3-blocker, 8% on an angiotensin converting enzyme inhibitor, 16% on a nitrate, 14% on a calcium antagonist, and 20% on a diuretic. There were no subsequent changes in drug therapy from day 7 to day 42 and no significant differences in drug therapy between late potential-positive and late potential-negative patients. One patient had a second infarction during the study period.
Change in Late Potential Status With Time
Twenty-nine percent of patients were late potentialpositive on their initial signal-averaged ECG on day 1. During the next week, there was a slight rise in the number of patients who were late potential-positive, reaching a peak of 42% on day 7 ( Table 2) . Subsequently, the incidence of late potentials fell to 13% on day 42.
To exclude any possible bias arising because of deaths, the incidence of late potentials was reassessed, excluding the six patients who died during the course of the study ( Table 2 ). The pattern of late potential positivity remained qualitatively similar. Excluding deaths 30 40 
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Five patients died suddenly after discharge and before day 42. The late potential status of these patients on days 1, 3, and 7 was: patient 1, positive day 7; patient 2, positive days 3 and 7; patient 3, positive days 1, 3, 7; patient 4, positive day 3; patient 5, negative days 1 and 3, no recording day 7.
Changes in End-Diastolic Volume
The mean end-diastolic volume index showed no significant change over the 6-week study period (Table  3 ). This apparent lack of change in the mean end-diastolic volume index conceals substantial variation between individual patients. The Patients who were late potential-negative on day 1 showed no significant change in ventricular end-diastolic volume index with time (Fig 2, A) . By contrast, late potential-positive patients showed a progressive and statistically significant increase in ventricular end-diastolic volume (P<.006 on day 42 compared with the late potential-negative group).
Similar results were evident for patients who were categorized according to late potential status on day 3 (Fig 2, B) . The late potential-positive group showed a progressive increase in ventricular end-diastolic volume index compared with the late potential-negative group (P<.002 on day 42).
For patients who were late potential-positive on day 7 (Fig 2, C) , increase in end-diastolic volume index was again significantly greater among late potential-positive patients (P<.04), although the difference was less marked than on days 1 and 3.
Consideration of patients who were late potentialpositive on day 42 (Fig 2, D) (Fig 3) . Late potentials on day 1 (Fig 3, A) were associated with a significant increase in end-systolic volume index to day 42, compared with the late potential-negative group (P<.004). Late potentials on day 3 (Fig 3, B) or day 7 (Fig 3, C) were similarly associated with a significant increase in end-systolic volume index to day 42 (P=.001 and P<.006, respectively). By contrast, late potentials on day 42 showed no association with change in endsystolic volume index (Fig 3, D) .
Change in Ejection Fraction
In contrast to diastolic and systolic volumes, ejection fraction did not show a clear relation to the presence of late potentials (Fig 4) . There was no statistically significant association between late potentials on day 1 (Fig 4,  A) or day 3 (Fig 4, B) and change in ejection fraction to day 42 . There was a weak association between late potentials on day 7 and change in ejection fraction (Fig  4, C, P=.04 ). There was no association between late potentials on day 42 and change in ejection fraction. Individual Signal-Averaging Parameters
The correlations between the three individual signalaveraging parameters (QRS duration, RMS voltage, and LAS duration) and change in end-diastolic volume index over the 6-week study period are presented in Table 5 . On day 1, the three parameters were only weakly correlated with change in end-diastolic volume index, with results bordering on statistical significance. On days 3 and 7, highly significant correlations were observed; correlations were significant for all three parameters, but QRS duration and LAS duration were more closely related to ventricular dilatation than was RMS voltage.
Variation in Late Potential Positivity
Considerable variability was observed in late potential activity among the three recordings in the first week after infarction (Table 6 ). The patients were divided into three groups: those positive for late potentials on all 3 recording days (n=9), those negative for late potentials on all 3 days (n=20), and those demonstrating dynamic late potentials present on one or two of the recording days but not all three (n=15).
Change in end-diastolic volume index among these three groups was considered (Fig 5) . Persistent groups, even when conventional criteria of late potential activity were negative.
Of the nine patients who were persistently late potential-positive throughout the first week, only two remained positive on day 42; six were late potentialnegative; one patient died. Persistent late potentials throughout the first week, therefore, do not result in long-term late potential positivity.
Comparison With Enzymatic and 12-Lead ECG Parameters
Peak creatine kinase activity was compared in the late potential-positive and -negative groups on each of the recording days (Table 7) . Positive late potentials were associated with a trend toward larger creatine kinase values, although this achieved statistical significance only on day 3 (P<.05).
No patients developed bundle branch block during the study. For both late potential-positive and late potential-negative groups, the mean QRS duration of the standard 12-lead ECG showed no significant change throughout the 6 weeks of the investigation. When 42 . An association between late potentials in the early postinfarct period and subsequent ventricular enlargement has not been reported previously.
Pathogenesis of Early-Phase Late Potentials
It is recognized that late potentials develop early after myocardial infarction.24 25 The fibrosis believed to under- Dynamic changes in positivity
Recordings incomplete 7 The patient who died in the first 48 hours was excluded. In seven patients, only two of the three recordings could be made, and these patients are listed as recordings incomplete. Fifteen Our findings suggest the possibility of a new application for signal averaging. The importance of ventricular enlargement as a determinant of subsequent prognosis is well recognized. The prevention of ventricular enlargement with angiotensin converting enzyme inhibitors in both the SAVE39 and SOLVD40 studies, corresponding to subacute and chronic phases after infarction, has been shown to improve mortality. However, the only large study of angiotensin converting enzyme inhibitors in the immediate postinfarction period (CONSENSUS II) failed to show any benefit in prognosis.41 CONSENSUS II treated all patients after infarction. It is apparent from our work and that of other investigators that only a relatively small proportion of patients who undergo thrombolysis will subsequently develop ventricular enlargement and are hence likely to benefit from therapeutic intervention to limit infarct expansion. Therefore, there is a need for an index in the immediate postinfarction period that will identify patients at risk of subsequent infarct expansion. It is tempting to suggest that early-phase late potentials 30 , Downloaded from http://ahajournals.org by on January 17, 2020 might fulfil this role through providing an indication of early myocyte slippage. This suggestion will, of course, require detailed prospective evaluation and comparison with other predictors of ventricular enlargement. In the present study, late potentials were much superior to Q waves in predicting ventricular enlargement.
It is possible, moreover, that different criteria of late potential activity would be superior in predicting ventricular enlargement. In the present investigation, conventional criteria derived from late-phase arrhythmia susceptibility studies have been used. It is conceivable that these criteria will benefit from modification when applied in the early postinfarct period to predict ventricular dilatation.
Relation to Thrombolysis
Recent studies have shown that persistent occlusion of the infarct-related artery predisposes to the development of late potentials.8'9'42'43 Similarly, persistent occlusion is known to predispose to infarct expansion and ventricular enlargement.4_5 It is possible, therefore, that persistent late potentials and delayed activation are merely an index of failed reperfusion.
Our study highlights the difference in incidence between late potentials in the first week after infarction and at 6 weeks in a population of patients, 92% of whom received thrombolytic therapy. Of 21 patients who were late potential-positive on day 7, only 7 (33%) remained positive at 6 weeks. Studies demonstrating a decreased incidence of late potentials in patients who received thrombolytic therapy have relied predominantly on late potentials assessed 1 week after infarction. Turitto and coworkers44 have shown that thrombolysis does not influence the incidence of late potentials recorded at a mean of 13 days after admission. There is growing evidence that the predictive value of late potentials after thrombolysis may differ from their value in the prethrombolytic era. 45 Our results indicate a need for caution in extrapolating from late potential activity in the first week to make inferences concerning the long-term effects of thrombolysis on late potential development.
Limitations of the Present Investigation
The study was intentionally limited to anterior infarcts. Anterior infarcts show a greater tendency to infarct expansion and ventricular dilatation than inferior infarcts and a higher specificity in the predictive value of late potentials. It was for these reasons that we chose to study this group. In the late postinfarct period, inferior infarcts are known to show a higher incidence of late potential positivity than anterior. It is possible, therefore, that the relations we have observed will not hold true for inferior infarction. This issue will require further investigation.
